InvestorsHub Logo
Followers 17
Posts 878
Boards Moderated 0
Alias Born 02/14/2020

Re: None

Tuesday, 04/07/2020 5:59:55 PM

Tuesday, April 07, 2020 5:59:55 PM

Post# of 35961
According to this article I found from Sept. 2018, Inspyr no longer controls the adenosine antagonists discussed in this forum... Could anyone here she's any more light on this...?

https://markets.businessinsider.com/news/stocks/inspyr-to-license-oncology-related-compounds-to-ridgeway-therapeutics-inc-1027539438

WESTLAKE VILLAGE, Calif., Sept. 17, 2018 Inspyr Therapeutics announced today that it has entered into an agreement with Ridgeway Therapeutics Inc. in which Ridgeway will license and assume control of certain assets relating to Inspyr's oncology development programs, including intellectual property rights relating to adenosine antagonists owned by Inspyr.